Prostaglandin insert dinoprostone versus trans-cervical balloon catheter for outpatient labour induction: a randomised controlled trial of feasibility (PROBIT-F)

Amarnath Bhide, Philip Sedgwick, Barbara Barrett, Georgina Cupples, Rose Coates, Rosie Goode, Sandra Linton, Christine McCourt, Amarnath Bhide, Philip Sedgwick, Barbara Barrett, Georgina Cupples, Rose Coates, Rosie Goode, Sandra Linton, Christine McCourt

Abstract

Background: The aim was to assess the feasibility of conducting a randomised controlled trial (RCT) of induction of labour comparing use of two methods in the outpatient setting.

Methods: An open-label feasibility RCT was conducted in two UK maternity units from October 2017 to March 2019. Women aged ≥ 16 years, undergoing induction of labour (IOL) at term, with intact membranes and deemed suitable for outpatient IOL according to local guidelines were considered eligible. They were randomised to cervical ripening balloon catheter (CRB) or vaginal dinoprostone (Propess). The participants completed a questionnaire and a sub-group underwent detailed interview. Service use and cost data were collected via the Adult Service Use Schedule (AD-SUS). Women who declined to participate were requested to complete a decliners' questionnaire.

Results: During the study period, 274 eligible women were identified. Two hundred thirty (83.9%) were approached for participation of whom 84/230 (36.5%) agreed and 146 did not. Of these, 38 were randomised to Propess (n = 20) and CRB (n = 18). Decliner data were collected for 93 women. The reasons for declining were declining IOL (n = 22), preference for inpatient IOL (n = 22) and preference for a specific method, Propess (n = 19). The intended sample size of 120 was not reached due to restrictive criteria for suitability for outpatient IOL, participant preference for Propess and shortage of research staff.The intervention as randomised was received by 29/38 (76%) women. Spontaneous vaginal delivery was observed in 9/20 (45%) women in the dinoprostone group and 11/18 (61%) women in the CRB group. Severe maternal adverse events were recorded in one woman in each group. All babies were born with good condition and all except one (37/38, 97.4%) remained with the mother after delivery. No deaths were recorded. - 21% of women in the dinoprostone group were re-admitted prior to diagnosis of active labour compared to 12% in the CRB group.

Conclusions: A third of the approached eligible women agreed for randomisation. An RCT is not feasible in the current service context. Modifications to the eligibility criteria for outpatient IOL, better information provision and round the clock availability of research staff would be needed to reach sufficient numbers.

Trial registration: NCT03199820. Registered on June 27, 2017.

Keywords: Cervical ripening; Cook cervical ripening balloon; Labour, induced; Outpatients; Randomised controlled trial; feasibility.

Conflict of interest statement

Competing interestsNone

© The Author(s) 2020.

Figures

Fig. 1
Fig. 1
CONSORT diagram of the trial

References

    1. NHS Digital SCT. NHS maternity Statistics. 2017-18. . Published 2018. Accessed 23/09/2019.
    1. Kelly AJ, Alfirevic Z, Ghosh A. Outpatient versus inpatient induction of labour for improving birth outcomes. Cochrane Database Syst Rev. 2013;11:CD007372.
    1. de Vaan MD, Ten Eikelder ML, Jozwiak M, et al. Mechanical methods for induction of labour. Cochrane Database Syst Rev. 2019;10:CD001233.
    1. Henry A, Madan A, Reid R, et al. Outpatient Foley catheter versus inpatient prostaglandin E2 gel for induction of labour: a randomised trial. BMC Pregnancy Childbirth. 2013;13:25. doi: 10.1186/1471-2393-13-25.
    1. Jozwiak M, Oude Rengerink K, Benthem M, et al. Foley catheter versus vaginal prostaglandin E2 gel for induction of labour at term (PROBAAT trial): an open-label, randomised controlled trial. Lancet. 2011;378(9809):2095–2103. doi: 10.1016/S0140-6736(11)61484-0.
    1. Pennell CE, Henderson JJ, O’Neill MJ, McChlery S, Doherty DA, Dickinson JE. Induction of labour in nulliparous women with an unfavourable cervix: a randomised controlled trial comparing double and single balloon catheters and PGE2 gel. BJOG. 2009;116(11):1443–1452. doi: 10.1111/j.1471-0528.2009.02279.x.
    1. Wilkinson C, Bryce R, Adelson P, Turnbull D. A randomised controlled trial of outpatient compared with inpatient cervical ripening with prostaglandin E(2) (OPRA study) BJOG. 2015;122(1):94–104. doi: 10.1111/1471-0528.12846.
    1. Balloon Catheter Versus Propess for Labour Induction (PROBIT-F). . Accessed 23/09/2019.
    1. No authoirs listed. NIHR rfpb program guidance. ). Accessed 24/05/2020.
    1. Teare MD, Dimairo M, Shephard N, Hayman A, Whitehead A, Walters SJ. Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study. Trials. 2014;15:264. doi: 10.1186/1745-6215-15-264.
    1. Wilkinson EL, O’Mahen HA, Fearon P, et al. Adapting and testing a brief intervention to reduce maternal anxiety during pregnancy (ACORN): study protocol for a randomised controlled trial. Trials. 2016;17:156. doi: 10.1186/s13063-016-1274-8.
    1. Eldridge SM, Chan CL, Campbell MJ, et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ. 2016;355:i5239. doi: 10.1136/bmj.i5239.
    1. Sharp AN, Stock SJ, Alfirevic Z. Outpatient induction of labour in the UK: a survey of practice. Eur J Obstet Gynecol Reprod Biol. 2016;204:21–23. doi: 10.1016/j.ejogrb.2016.06.023.
    1. Turnbull D, Adelson P, Oster C, et al. The impact of outpatient priming for induction of labour on midwives’ work demand, work autonomy and satisfaction. Women Birth. 2013;26(3):207–212. doi: 10.1016/j.wombi.2013.03.001.
    1. Du YM, Zhu LY, Cui LN, Jin BH, Ou JL. Double-balloon catheter versus prostaglandin E2 for cervical ripening and labour induction: a systematic review and meta-analysis of randomised controlled trials. BJOG. 2017;124(6):891–899. doi: 10.1111/1471-0528.14256.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera